share_log

Anavex Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Velden Claus Vander

SEC ·  Feb 23, 2024 19:09
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more